137 related articles for article (PubMed ID: 38499636)
1. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract][Full Text] [Related]
2. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
3. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.
Dai L; Pan G; Liu X; Huang J; Jiang Z; Zhu X; Gan X; Xu Q; Tan N
Cancer Manag Res; 2018; 10():1799-1806. PubMed ID: 29988738
[TBL] [Abstract][Full Text] [Related]
4. Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway.
Lu Y; Zhang Y; Wang X; Zhang H; Zhu Y; Zhang J; Sha H; Zou R; Gan Y; Sui Y; Wang J; Du T; Wu J; Feng J
Dis Markers; 2023; 2023():1702125. PubMed ID: 37457886
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.
Tian W; Zhou J; Chen M; Qiu L; Li Y; Zhang W; Guo R; Lei N; Chang L
Sci Rep; 2022 Jul; 12(1):11632. PubMed ID: 35804089
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
7. NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA.
Wang C; Xin H; Yan G; Liu Z
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36929422
[TBL] [Abstract][Full Text] [Related]
8. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
9. High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma.
Tang Y; Yang X; Feng K; Hu C; Li S
J Gastrointest Oncol; 2021 Feb; 12(1):174-183. PubMed ID: 33708434
[TBL] [Abstract][Full Text] [Related]
10. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target.
Chen L; Wu Z; Guo J; Wang X; Zhao Z; Liang H; Zhang R; Deng J
Clin Exp Med; 2023 Oct; 23(6):2443-2456. PubMed ID: 36422738
[TBL] [Abstract][Full Text] [Related]
11. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis.
Li CH; Chan MH; Chang YC
Aging (Albany NY); 2022 Apr; 14(7):3233-3258. PubMed ID: 35404841
[TBL] [Abstract][Full Text] [Related]
12. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
13. ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
Li J; Wang F; Gao H; Huang S; Cai F; Sun J
J Cell Biochem; 2019 Aug; 120(8):13694-13705. PubMed ID: 31081974
[TBL] [Abstract][Full Text] [Related]
14. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
Wang D; Xu MR; Wang T; Li T; Zhu Jw
J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
[TBL] [Abstract][Full Text] [Related]
15. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
[TBL] [Abstract][Full Text] [Related]
16. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
17. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
[TBL] [Abstract][Full Text] [Related]
18. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness.
Chang YC; Yang YF; Chiou J; Tsai HF; Fang CY; Yang CJ; Chen CL; Hsiao M
Cell Death Dis; 2020 Mar; 11(3):195. PubMed ID: 32188842
[TBL] [Abstract][Full Text] [Related]
19. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer.
Maruyama R; Nagaoka Y; Ishikawa A; Akabane S; Fujiki Y; Taniyama D; Sentani K; Oue N
Pathol Int; 2022 Mar; 72(3):176-186. PubMed ID: 35147255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]